HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Best Wellness Innovation Group / Equity Capital Markets

<ul>
<li>The growth in revenue and profit was mainly driven by the face mask business, but this business has ceased, which raises the concerns on future growth momentum of Best Wellness.</li>
<li>Best Wellness’s weak performance of its own-brand business would prevent it from standing out in the fierce market competition in the long term. </li>
<li>Together with over-reliance on limited customers and the complex international relations, we are conservative about the Company’s outlook at the current stage.</li>
</ul>


The growth in revenue and profit was mainly driven by the face mask business, but this business has ceased, which raises the concerns on future growth momentum of Best Wellness.
Best Wellness’s weak performance of its own-brand business would prevent it from standing out in the fierce market competition in the long term. 
Together with over-reliance on limited customers and the complex international relations, we are conservative about the Company’s outlook at the current stage.


Pre-IPO Best Wellness Innovation Group - Here Are the Concerns

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Best Wellness Innovation Group (BWI HK)

Pre-IPO Best Wellness Innovation Group - Here Are the Concerns

The performance was driven by face mask business, indicating lack of future growth momentum.Together with weak own-brand business/complex...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)